Prostatis Group LLC has filed its 13F form on August 14, 2023 for Q2 2023 where it was disclosed a total value porftolio of $215 Billion distributed in 250 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $11.9B, Invesco Qqq Trust, Series 1 with a value of $11.8B, Spdr Dow Jones Industrial Average ETF Trust with a value of $11.5B, Amplify ETF Tr Amplify Cwp Enh with a value of $11B, and Ark Autonomous Technology & Ro with a value of $10.3B.

Examining the 13F form we can see an increase of $25.5B in the current position value, from $189B to 215B.

Prostatis Group LLC is based out at Hanover, MD

Below you can find more details about Prostatis Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $215 Billion
ETFs: $178 Billion
Technology: $6.51 Billion
Industrials: $5.31 Billion
Financial Services: $3.98 Billion
Consumer Defensive: $3.55 Billion
Consumer Cyclical: $3.48 Billion
Healthcare: $3.35 Billion
Energy: $2.85 Billion
Other: $4.37 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 250
  • Current Value $215 Billion
  • Prior Value $189 Billion
  • Filing
  • Period Q2 2023
  • Filing Date August 14, 2023
  • Form Type 13F-HR
  • Activity in Q2 2023
  • New Purchases 155 stocks
  • Additional Purchases 83 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.